Nobiletin Enhances Chemosensitivity to Adriamycin through Modulation of the Akt/GSK3β/β–Catenin/MYCN/MRP1 Signaling Pathway in A549 Human Non-Small-Cell Lung Cancer Cells
- Supplementary File 1:
PDF-Document (PDF, 347 KiB)
Moon, J.Y.; Manh Hung, L.V.; Unno, T.; Cho, S.K. Nobiletin Enhances Chemosensitivity to Adriamycin through Modulation of the Akt/GSK3β/β–Catenin/MYCN/MRP1 Signaling Pathway in A549 Human Non-Small-Cell Lung Cancer Cells. Nutrients 2018, 10, 1829. https://doi.org/10.3390/nu10121829
Moon JY, Manh Hung LV, Unno T, Cho SK. Nobiletin Enhances Chemosensitivity to Adriamycin through Modulation of the Akt/GSK3β/β–Catenin/MYCN/MRP1 Signaling Pathway in A549 Human Non-Small-Cell Lung Cancer Cells. Nutrients. 2018; 10(12):1829. https://doi.org/10.3390/nu10121829
Chicago/Turabian StyleMoon, Jeong Y., Le V. Manh Hung, Tatsuya Unno, and Somi K. Cho. 2018. "Nobiletin Enhances Chemosensitivity to Adriamycin through Modulation of the Akt/GSK3β/β–Catenin/MYCN/MRP1 Signaling Pathway in A549 Human Non-Small-Cell Lung Cancer Cells" Nutrients 10, no. 12: 1829. https://doi.org/10.3390/nu10121829